Hint mode is switched on Switch off

BIB - ProShares Ultra Nasdaq Biotechnology (USD) (US74347R2141)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

FIND, SAVE & TRACK INVESTMENTS WITH CBONDS WATCHLIST

With Cbonds Watchlist you can always stay updated on your investments to make conscious decisions!

Watchlist
You need to request access
Cbonds API
Bring Market Data into Your Systems

Access ETF and Mutual Funds Data via API

  • Prices & NAV
  • Fund Structure
  • Inflows & dividends

Choose all Reset all

Leveraged

 
(%)
US74347R2141
BIB ISIN
Exchange Traded Funds (ETF)
Type of fund
ProShares
Provider
113.42 USD
NAV per Share | 21/09/2026
07/04/2010
Inception Date
4 times per year
Dividend payments
CEOJLS
CFI
BIB
Ticker
Formed
Status
Equity
Investment category
Biotech
Sector
USA
Investor locations
Nasdaq Biotechnology® Index
Benchmark
0.95 %
Total Cost Ratio
95.28 mln USD
Fund NAV | 21/09/2026
95.28 mln USD
Share Class NAV | 21/09/2026
No
UCITS
Included in the Free Plan
  • 100,000+ Stocks
  • 17,000+ ETFs
  • 150,000+ Mutual Funds

Start exploring global markets in less than 1 minute

  • Global Macro & Commodity Data
  • Research Hub & Basic Market News
  • AI Bond Screener
Free Plan

Yield on 21/09/2026, NASDAQ

  • YTD
    42.5 %
  • 1M
    -7.11 %
  • 3M
    33.46 %
  • 6M
    51.15 %
  • 1Y
    96.27 %
  • 3Y
    141.29 %
  • 5Y
    11.75 %
  • 10Y
    127.32 %
At the price on the exchange, taking into account income payments

Latest data on
Add to compare
from
to
ADD-IN
Cbonds add-in API
bond data api

Quotes (BIB)

Explore the most comprehensive database

1 000 000

bonds

100 000

stocks

175 910

ETF & Funds

100 000

indices

Track your portfolio in the most efficient way

  • Bond Search
  • Watchlist
  • Excel ADD-IN
Get access
×

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 1 000 000 bonds, 100 000 stocks, 100 000 indices, 17 000 ETF and 150 000 Mutual Funds; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Register
×

Why

You will have detailed descriptive & pricing data for 1M bonds, 100K stocks, 100K indices, 17K ETF and 150K Mutual Funds
Get full access to the platform from any device & via Cbonds app
Enhance your portfolio management with Cbonds Excel Add-in
Build yield maps, make chart comparison within a click
Don't wait any longer — start using Cbonds today! Register

Price dynamics

BIB profile

The ProShares Ultra Nasdaq Biotechnology (USD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Biotech sector located in USA. The ProShares fund’s base currency is USD and the share class was registered 07.04.2010 with unique ISIN - US74347R2141. Main exchange is NASDAQ and ticker symbol is BIB. The total expense ratio is 0.95%. The ProShares Ultra Nasdaq Biotechnology (USD) pays dividends 4 time(s) per year.

Structure BIB on 21/09/2026

Download structure in Excel
Paper Value
TRAVERE THERAPEUTICS INC 0%
ACADIA PHARMACEUTICALS INC 0%
IOVANCE BIOTHERAPEUTICS INC 0%
GRAIL INC 0%
EDGEWISE THERAPEUTICS INC 0%
ERASCA INC 0%
DEFINIUM THERAPEUTICS INC 0%
PTC THERAPEUTICS INC 0%
COGENT BIOSCIENCES INC 0%
CRISPR THERAPEUTICS AG 0%
LIGAND PHARMACEUTICALS 0%
SCHOLAR ROCK HOLDING CORP 0%
ABIVAX SA-ADR 0%
ADAPTIVE BIOTECHNOLOGIES 0%
MIRUM PHARMACEUTICALS INC 0%
ORUKA THERAPEUTICS INC 0%
RHYTHM PHARMACEUTICALS INC 0%
CG ONCOLOGY INC 0%
AMNEAL PHARMACEUTICALS INC 0%
ALKERMES PLC 0%
IONIS PHARMACEUTICALS INC 0%
IMMUNOVANT INC 0%
SPYRE THERAPEUTICS INC 0%
PRAXIS PRECISION MEDICINES I 0%
CARIS LIFE SCIENCES INC 0%
VERACYTE INC 0%
MINERALYS THERAPEUTICS INC 0%
PHARVARIS NV 0%
BEAM THERAPEUTICS INC 0%
DISC MEDICINE INC 0%
NURIX THERAPEUTICS INC 0%
PRECIGEN INC 0%
MBX BIOSCIENCES INC 0%
STRUCTURE THERAPEUTICS INC 0%
UNIQURE NV 0%
DYNE THERAPEUTICS INC 0%
ARCUTIS BIOTHERAPEUTICS INC 0%
DENALI THERAPEUTICS INC 0%
VAXCYTE INC 0%
GENMAB A/S -SP ADR 0%
TARSUS PHARMACEUTICALS INC 0%
ENLIVEN THERAPEUTICS INC 0%
IDEAYA BIOSCIENCES INC 0%
TANGO THERAPEUTICS INC 0%
KINIKSA PHARMACEUTICALS INTE 0%
XENON PHARMACEUTICALS INC 0%
RELAY THERAPEUTICS INC 0%
AMYLYX PHARMACEUTICALS INC 0%
ABCELLERA BIOLOGICS INC 0%
INDIVIOR PHARMACEUTICALS INC 0%
AMGEN INC 0%
GUARDANT HEALTH INC 0%
INCYTE CORP 0%
ROYALTY PHARMA PLC- CL A 0%
INSMED INC 0%
ARGENX SE - ADR 0%
ROIVANT SCIENCES LTD 0%
BIOGEN INC 0%
ALNYLAM PHARMACEUTICALS INC 0%
ILLUMINA INC 0%
REVOLUTION MEDICINES INC 0%
MODERNA INC 0%
REGENERON PHARMACEUTICALS 0%
UNITED THERAPEUTICS CORP 0%
VERTEX PHARMACEUTICALS INC 0%
GILEAD SCIENCES INC 0%
THIRD HARMONIC BIO INC 0%
CARTESIAN THERAPEUTICS-CVR 0%
NEWAMSTERDAM PHARMA CO NV 0%
PROSHARES GENIUS MNY MKT ETF 0%
NASDAQ Biotechnology Index SWAP UBS AG 0%
NASDAQ Biotechnology Index SWAP Societe Generale 0%
NASDAQ Biotechnology Index SWAP Goldman Sachs International 0%
NASDAQ Bio Index SWAP BNP Paribas 0%
NASDAQ Biotechnology Index SWAP Citibank NA 0%
BIOMARIN PHARMACEUTICAL INC 0%
IMMUNITYBIO INC 0%
SANOFI-ADR 0%
PROTAGONIST THERAPEUTICS INC 0%
CYTOKINETICS INC 0%
10X GENOMICS INC-CLASS A 0%
ARROWHEAD PHARMACEUTICALS IN 0%
KYMERA THERAPEUTICS INC 0%
KRYSTAL BIOTECH INC 0%
AXSOME THERAPEUTICS INC 0%
TWIST BIOSCIENCE CORP 0%
BIONTECH SE-ADR 0%
MADRIGAL PHARMACEUTICALS INC 0%
NASDAQ Biotechnology Index SWAP Bank of America NA 0%
HALOZYME THERAPEUTICS INC 0%
BEONE MEDICINES LTD-ADR 0%
BRIDGEBIO PHARMA INC 0%
SUMMIT THERAPEUTICS INC 0%
TEMPUS AI INC-CL A 0%
EXELIXIS INC 0%
ASCENDIS PHARMA A/S 0%
NEUROCRINE BIOSCIENCES INC 0%
JAZZ PHARMACEUTICALS PLC 0%
MEDPACE HOLDINGS INC 0%
VIATRIS INC 0%
Show more Hide
Other - %
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Unlock data Watch full tour

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Other ETF & Funds from this provider

Similar ETF & Funds

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} mln
    NAV
    {{ item.expense_ratio }}
    Total Cost Ratio
Registration is required to get access.